METHOD OF NEUTRALISATION OF HEPATITIS C VIRUS, COMPLETELY HUMAN HOMOGENEOUS ANTIBODY AGAINST HEPATITIS C VIRUS (VERSIONS), COMPOSITION OF COMPLETELY HUMAN HOMOGENEOUS ANTIBODIES AGAINST HEPATITIS C VIRUS AND HYBRID MOUSE/HUMAN CELL LINE - PRODUCENT OF COMPLETELY HUMAN HOMOGENEOUS ANTIBODIES AGAINST HEPATITIS C VIRUS (VERSIONS) Russian patent published in 2015 - IPC C12N7/00 C07K16/10 A61K39/42 C12N5/10 

Abstract RU 2539770 C1

FIELD: medicine.

SUBSTANCE: invention relates to field of biotechnology. Disclosed are methods and technologies of hepatitis C virus neutralisation, as well as antibodies against hepatitis C virus. It is suggested to apply completely human homogeneous antibodies RYB1, RYB2 and RYB3, as well as compositions on their base for prevention and treatment of hepatitis C. Said antibodies are obtained by cultivation by hybrid BIONA-RYB1, BIONA-RYB2 and BIONA-RYB3. Efficiency of antibodies is conditioned by the fact that they bind epitopes, respectively, E1, E2, E3 of protein E2 of hepatitis C virus envelope. Neutralising activity of antibodies on modal system of human cells infection in culture is demonstrated. It is shown that application of claimed group of inventions makes it possible to increase reliability of binding hepatitis C virus by antibodies.

EFFECT: claimed group of inventions can be applied in medicine, pharmaceutical industry and close fields of science and technique.

9 cl, 9 dwg, 8 tbl, 13 ex

Similar patents RU2539770C1

Title Year Author Number
COMPOSITION FOR DIAGNOSIS OF HUMAN HEPATITIS C (VARIANTS), METHOD AND SET FOR DETECTION OF ANTIBODIES TO HUMAN HEPATITIS C VIRUS 1991
  • Majkl Khaugton
  • Kuj-Lim Choo
  • Dzhordzh Kuo
RU2130969C1
OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS 1999
  • Depla Ehrik
  • Martens Gert
  • Bosman Al'Fons
  • Van Vejnendale Frans
RU2247729C2
NEW ANTIBODIES AGAINST HEPATITIS B VIRUS AND APPLICATION THEREOF 2020
  • Luo, Wenxin
  • Wen, Can
  • Xiang, Xinchu
  • Tang, Jixian
  • Wu, Yangtao
  • Zhang, Tianying
  • Yuan, Quan
  • Xia, Ningshao
RU2814471C2
MONOCLONAL ANTIBODIES AGAINST RABIES VIRUS AND MIXTURE THEREOF 2019
  • Mendiratta, Sanjeev Kumar
  • Bandyopadhyay, Sanjay
  • Kalita, Pankaj
  • Kansagra, Kevinkumar
RU2822457C2
ANTIBODIES AGAINST HEPATITIS B VIRUS AND THEIR USE 2020
  • Luo, Wenxin
  • Jiang, Yichao
  • Yu, Chao
  • Chen, Xiaoqing
  • Tang, Jixian
  • Yuan, Quan
  • Zhang, Tianying
  • Xia, Ningshao
RU2803082C2
BTN2-SPECIFIC ANTIBODIES AND USE THEREOF 2020
  • Foucher, Etienne
  • Cano, Carla
  • Le, Kieu Suong
  • Pasero, Christine
  • Olive, Daniel
RU2821703C2
CHEMERICAL ANTIGENES FOR VACCINE AGAINST HEPATITIS C VIRUS 2013
  • Duenyas Karrera Santyago
  • Agilar Norega Dajlen
  • Amador Kanisares Yalena
  • Alvares-Lakhonchere Ponse De Leon Lis
  • Martines Donato Khilyan
  • Gonsales Blanko Sonya
RU2639504C2
HUMANIZED MONOCLONAL ANTIBODY AGAINST Aβ AND ITS USE 2020
  • Feng, Xiao
  • Liang, Yangqiu
  • Jin, Lei
  • Sun, Dawei
  • Wang, Tao
  • Xiao, Liang
  • Liu, Shuang
  • Chen, Yuheng
  • Li, Zhengyi
RU2783528C1
NEUTRALIZING ANTIBODIES AGAINST THE INFLUENZA A VIRUS AND WAYS OF THEIR APPLICATION 2014
  • Benjamin, Ebony
  • Kallewaard-Lelay, Nicole
  • Mcauliffe, Josephine, Mary
  • Palmer-Hill, Frances
  • Wachter, Leslie
  • Yuan, Andy
  • Zhu, Qing
  • Corti, Davide
  • Lanzavecchia, Antonio
  • Guarino, Barbara
  • Demarco, Anna
RU2803850C2
BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION 2019
  • Liu Zhigang
  • Hao Xiaobo
  • Liu Yulan
  • Guo Jingjing
RU2764740C1

RU 2 539 770 C1

Authors

Vlasik Tat'Jana Nikolaevna

Rybalkin Igor' Nikolaevich

Sadgjan Armen Sergeevich

Shevelev Aleksandr Jasenovich

Dates

2015-01-27Published

2013-12-27Filed